There are limited tariff risks. Lonza is a potential beneficiary given the ample availability of the USA industrial capacities should biotech or pharma have onshoring needs. With profit growth ...

Lonza, the Swiss Biotech firm that purchased Vacaville’s Genentech plant from Roche in 2024, released a streamlined operating model and invitations to its Annual General Meeting in Basel ...

On Wednesday, Morgan Stanley (NYSE:MS) analysts adjusted their stance on Lonza Group (LONN:SW) (OTC: LZAGY), downgrading the stock from Overweight to Equalweight, while increasing the price target ...

The extended agreement will expand the dedicated bioconjugation footprint for the customer through the construction of a new bioconjugation suite at Lonza’s Ibex ® Biopark in Visp (CH). In addition, ...

The issuer is solely responsible for the content of this announcement. Basel, Switzerland, 3 April 2025 – Lonza today announced the publication of its 2024 Annual and Sustainability Reports, as well ...

Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy Previous divisional structure is now replaced with three newly formed CDMO Business ...